US equities |
NVDA $173.72 ▲+2.86% MU $767.01 ▲+5.78% AMD $531.95 ▲+3.25% SPCX $143.75 ▲+0.46% SNDK $934.04 ▲+8.61% CRWV $54.15 ▲+11.12% AVGO $350.82 ▲+5.68% TSLA $389.94 ▲+2.68%
FinancialContent

Johnson & Johnson (NY:JNJ)

277.44 -3.34 (-1.19%)
Delayed Quote Updated: 9:35 AM EST, Nov 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Johnson & Johnson - JNJ
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Johnson & Johnson - JNJ
From Pomerantz LLP
Via GlobeNewswire
News headline image
Data Show Positive Survival and Patient Outcomes with Best-Practice Impella Support in HRPCI, in Contrast to CHIP-BCIS3 Study Results
From Johnson & Johnson
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Johnson & Johnson - JNJ
From Pomerantz LLP
Via GlobeNewswire
News headline image
Johnson & Johnson to Host Enterprise Business Review
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Reports First Real-World VARIPULSE Pro Platform Data and 12-Month OMNYPULSE Platform Outcomes for Atrial Fibrillation Treatment at APHRS 2026
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Launches Next-Generation Shockwave™ C2 Aero Fly Coronary IVL Catheter, Cutting IVL Treatment Time in Half
From Johnson & Johnson
Via Business Wire
News headline image
JNJ Investors with $100,000 in Losses Have Opportunity to Join Johnson & Johnson Fraud Investigation with SBS Law
From Schall, Brown & Schwartz LLP
Via Business Wire
News headline image
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2026
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson reports Q3 2026 results, raises 2026 guidance
From Johnson & Johnson
Via Business Wire
News headline image
DocMagic’s Lori Johnson named a 2026 Powerful Woman of Mortgage Banking
TORRANCE, Calif., Oct. 8, 2026 (SEND2PRESS NEWSWIRE) -- DocMagic® announced today that Chief Operating Officer Lori Johnson has been named one of Mortgage Banker's 2026 Powerful Women of Mortgage... 
Via Send2Press
News headline image
New Global Survey by Johnson & Johnson Finds Most Women Don’t Connect Eye Health Changes with Menopause
From Johnson & Johnson
Via Business Wire
News headline image
DePuy Synthes Showcases Next-Generation Trauma Innovations at OTA 2026
From DePuy Synthes
Via Business Wire
News headline image
Johnson & Johnson Receives CE Marking for ACUVUE OASYS MAX Reusable Contact Lenses
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson to Participate in the Deutsche Bank 2026 Healthcare Summit
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
News headline image
A CEO With a Proven Track Record of Success in Growing and Scaling Biopharmaceutical Companies Just Appointed CEO at a Clinical-Stage Biotech, Months Before Its Pivotal Phase 3 Readout
Issued on behalf of Helus Pharma (Nasdaq: HELP) 
From USA News Group
Via GlobeNewswire
News headline image
Johnson & Johnson to Participate in the 2026 Wells Fargo Healthcare Conference
From Johnson & Johnson
Via Business Wire
News headline image
Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One
Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU) 
From American News Group
Via GlobeNewswire
News headline image
Johnson & Johnson’s Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Announces Collaboration with Sail Biomedicines to Advance in vivo CAR-T Programs and Transform Autoimmune Disease Through Immune Reset
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Announces a Proposed Resolution of Ovarian Talc Litigation
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Receives FDA Market Authorization in the U.S. for its OTTAVA™ Robotic Surgical System
From Johnson & Johnson
Via Business Wire
News headline image
Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates
EQNX::TICKER_START (NASDAQ:HELP),(NASDAQ:CMPS),(NASDAQ:ATAI),(NYSE:JNJ),(NYSE:LLY) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
News headline image
Johnson & Johnson Announces Collaboration with TIME to Introduce New Healthcare Champion of the Year Award
From Johnson & Johnson
Via Business Wire
News headline image
DePuy Synthes Acquires Expanding Innovations™
From DePuy Synthes
Via Business Wire
News headline image
Author’s Tranquility Press Announces a Powerful New Memoir of Faith, Survival, and Purpose
Via AB Newswire
News headline image
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2026
From Johnson & Johnson
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >